Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
64,139.00
62,843.00
60,461.00
56,607.00
55,181.00
52,542.00
46,705.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
64,139.00
62,843.00
60,461.00
56,607.00
55,181.00
52,542.00
46,705.00
Raw Material Cost
32,803.00
32,178.00
31,876.00
30,255.00
29,798.00
28,525.00
27,814.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
51.00
40.00
50.00
56.00
59.00
64.00
41.00
Selling and Distribution Expenses
18,972.00
19,436.00
19,249.00
17,958.00
21,773.00
17,596.00
12,614.00
Other Expenses
698.00
468.80
417.70
354.20
-5.90
484.90
445.20
Total Expenditure (Excl Depreciation)
58,806.00
56,342.00
55,352.00
51,811.00
51,571.00
51,034.00
44,921.00
Operating Profit (PBDIT) excl Other Income
5333
6501
5109
4796
3610
1508
1784
Other Income
1,212.00
3,404.00
300.00
9,567.00
31.00
321.00
345.00
Operating Profit (PBDIT)
8,792.00
12,567.00
8,536.00
17,248.00
7,003.00
5,590.00
4,747.00
Interest
51.00
40.00
50.00
56.00
59.00
64.00
41.00
Exceptional Items
-300.00
0.00
0.00
-8,141.00
-8.00
-862.00
-203.00
Gross Profit (PBDT)
31,336.00
30,665.00
28,585.00
26,352.00
25,383.00
24,017.00
18,891.00
Depreciation
2,247.00
2,662.00
3,127.00
2,885.00
3,362.00
3,761.00
2,618.00
Profit Before Tax
6,192.00
9,862.00
5,357.00
6,163.00
3,575.00
901.00
1,883.00
Tax
1,091.00
2,316.00
1,118.00
1,873.00
861.00
252.00
138.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
5,101.00
7,545.00
4,238.00
4,290.00
2,713.00
649.00
1,744.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
5,101.00
7,545.00
4,238.00
4,290.00
2,713.00
649.00
1,744.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
5,101.00
7,545.00
4,238.00
4,290.00
2,713.00
649.00
1,744.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
65,310.00
61,930.00
54,533.00
48,892.00
44,510.00
41,573.00
43,456.00
Earnings per share (EPS)
179.95
266.49
150.08
151.22
95.63
22.94
61.8
Diluted Earnings per share
179.95
266.49
150.08
151.22
95.63
22.94
61.8
Operating Profit Margin (Excl OI)
8.31%
10.34%
8.45%
8.47%
6.54%
2.87%
3.82%
Gross Profit Margin
13.16%
19.93%
14.03%
15.98%
12.57%
8.87%
9.64%
PAT Margin
7.95%
12.01%
7.01%
7.58%
4.92%
1.24%
3.73%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 2.06% vs 3.94% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is -32.39% vs 78.03% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -17.28% vs 11.26% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 27.50% vs -20.00% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of ASKA Pharmaceutical Holdings Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(JPY)
Change(%)
Net Sales
64,139.00
39,424.00
24,715.00
62.69%
Other Operating Income
0.00
0.00
0.00
Total Operating income
64,139.00
39,424.00
24,715.00
62.69%
Raw Material Cost
32,803.00
24,965.00
7,838.00
31.40%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
51.00
141.00
-90.00
-63.83%
Selling and Distribution Expenses
18,972.00
8,195.00
10,777.00
131.51%
Other Expenses
698.00
199.80
498.20
249.35%
Total Expenditure (Excl Depreciation)
58,806.00
35,299.00
23,507.00
66.59%
Operating Profit (PBDIT) excl Other Income
5,333.00
4,125.00
1,208.00
29.28%
Other Income
1,212.00
4,317.00
-3,105.00
-71.92%
Operating Profit (PBDIT)
8,792.00
11,264.00
-2,472.00
-21.95%
Interest
51.00
141.00
-90.00
-63.83%
Exceptional Items
-300.00
-902.00
602.00
66.74%
Gross Profit (PBDT)
31,336.00
14,459.00
16,877.00
116.72%
Depreciation
2,247.00
2,822.00
-575.00
-20.38%
Profit Before Tax
6,192.00
7,398.00
-1,206.00
-16.30%
Tax
1,091.00
3,653.00
-2,562.00
-70.13%
Provisions and contingencies
0
0
0.00
Profit After Tax
5,101.00
3,525.00
1,576.00
44.71%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
5,101.00
3,525.00
1,576.00
44.71%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
219.00
-219.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
5,101.00
3,744.00
1,357.00
36.24%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
65,310.00
86,038.00
-20,728.00
-24.09%
Earnings per share (EPS)
179.95
107.70
72.25
67.08%
Diluted Earnings per share
179.95
107.70
72.25
67.08%
Operating Profit Margin (Excl OI)
8.31%
10.46%
0.00
-2.15%
Gross Profit Margin
13.16%
25.92%
0.00
-12.76%
PAT Margin
7.95%
8.94%
0.00
-0.99%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 6,413.90 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 2.06% vs 3.94% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 510.10 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -32.39% vs 78.03% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 758.00 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -17.28% vs 11.26% in Mar 2024
Annual - Interest
Interest 5.10 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 27.50% vs -20.00% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.31%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
